Identification, Management, Caring for Children with Fragile X Syndrome Virtual Course
By Hilary Rosselot
The American Academy of Pediatrics (AAP), with support from the CDC, hosted “Identification, Management, Caring for Children with Fragile X Syndrome Virtual Course” on June 22, 2022, which will be available as a free AAP course through August 1, 2025.
The CDC, who funds our long-time FORWARD Registry and Database, connected the National Fragile X Foundation with the AAP team working on this course. We were able to make recommendations to the course thanks to the CDC’s invitation.
Participants will learn skills to identify, manage, and care for children and adolescents with Fragile X syndrome, from leading experts on diagnosis, genetic testing, family support, and management strategies for patients with Fragile X syndrome. The course experts will be very familiar to the Fragile X community:
- Jayne Dixon Weber, community education director for NFXF.
- Dr. Reymundo Lozano from the Icahn School of Medicine at Mount Sinai.
- Dr. Nicole Tartaglia from the University of Colorado School of Medicine, Children’s Hospital Colorado. Dr. Tartaglia is also a member of the NFXF Scientific and Clinical Advisory Committee.
How to Take the Course
The event recording is available as a free online course through August 1, 2025. Anyone can participate in this course. Professionals may earn CME/MOC Part 2 credit upon completion. To register:
- Attendees need to have an AAP account, if you don’t already have one you can set up a free AAP account.
- Sign up for the course at shopAAP.
Thank you to the AAP and CDC for helping raise awareness for Fragile X!
about
Hilary Rosselot
Hilary joined the NFXF team in 2019. Prior to joining the NFXF team, she worked at the Cincinnati Fragile X Research and Treatment Center for over five years. She has experience as a clinical research coordinator across many types of clinical trials and served as the clinical research manager for the Cincinnati program. She earned a bachelor’s degree in psychology, a master’s, and is a SOCRA certified clinical research professional (CCRP). She enjoys time with family and friends, a great book, a strong cup of coffee and, of course, a good laugh!
Adults with Fragile X Syndrome:
Making a Better Tomorrow
We have built the ultimate guide on transitioning into and continuing to care for adults with Fragile X syndrome. Our ebook includes chapters on:
Transition to Adult Services ♦ Transportation ♦ Housing ♦ Employment, Volunteering & Day Programs ♦ College & Post-Secondary Education ♦ Daily Living
learn more
Alcobra Ltd Announces a New Clinical Trial Enrolling Subjects with Fragile X Syndrome in 2014
Alcobra Ltd will be conducting a clinical trial of Metadoxine Extended Release (MDX) in adults and adolescents, 15 to 55 years old, with Fragile X syndrome. The planned Phase IIb MDX clinical trial will be a multi-center, randomized, placebo-controlled study, conducted primarily in the US. The study is supported by positive data collected from multiple earlier animal studies using metadoxine. Results from these studies demonstrated significant improvement in behavioral and cognitive outcomes in mice based on testing and performance of memory, learning, and social interaction.
Huber: A Response to "Marijuana-like Brain Chemicals" Possible Treatment for FXS
The Fox news piece highlighted an original research article, by Drs. Daniele Piomelli and Olivier Manzoni and colleagues, that found boosting the production of a natural marijuana-like chemical in the brain, 2-AG, called an endocannabinoid, could restore normal brain function and behavior in the mouse model of Fragile X. Although this finding is very exciting, don’t make the marijuana brownies just yet!